NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.94
Percentage change 1.65	%

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK VTI VB ARKG VBK ULTY IBB IWP JTEK BAI

Index	-	P/E	-	EPS (ttm)	-4.60	Insider Own	48.04%	Shs Outstand	167.99M	Perf Week	-0.33%
Market Cap	10.01B	Forward P/E	2429.41	EPS next Y	0.02	Insider Trans	-9.16%	Shs Float	89.95M	Perf Month	-18.31%
Enterprise Value	10.65B	PEG	-	EPS next Q	-0.23	Inst Own	33.06%	Short Float	24.51%	Perf Quarter	43.51%
Income	-721.31M	P/S	12.46	EPS this Y	54.57%	Inst Trans	-0.69%	Short Ratio	1.74	Perf Half Y	54.23%
Sales	803.32M	P/B	30.67	EPS next Y	103.32%	ROA	-70.47%	Short Interest	22.04M	Perf YTD	71.27%
Book/sh	1.89	P/C	45.75	EPS next 5Y	-	ROE	-	52W High	91.45 -36.77%	Perf Year	65.20%
Cash/sh	1.26	P/FCF	-	EPS past 3/5Y	-37.97% -32.48%	ROIC	-61.41%	52W Low	31.36 84.37%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	39.06% 38.58%	Gross Margin	55.42%	Volatility	4.27% 5.62%	Perf 5Y	-
Dividend TTM	-	EV/Sales	13.26	EPS Y/Y TTM	-160.27%	Oper. Margin	-87.17%	ATR (14)	3.87	Perf 10Y	-
Dividend Ex-Date	Jul 18, 2006	Quick Ratio	1.56	Sales Y/Y TTM	42.93%	Profit Margin	-89.79%	RSI (14)	42.32	Recom	2.08
Dividend Gr. 3/5Y	- -	Current Ratio	1.71	EPS Q/Q	27.16%	SMA20	-9.47%	Beta	5.18	Target Price	66.70
Payout	-	Debt/Eq	2.63	Sales Q/Q	75.38%	SMA50	-7.47%	Rel Volume	0.56	Prev Close	56.88
Employees	2400	LT Debt/Eq	2.60	Earnings	May 06 AMC	SMA200	7.57%	Avg Volume	12.70M	Price	57.82
IPO	Jun 14, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.69% 3.07%	Trades		Volume	7,109,245	Change	1.65%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42
Jul-09-24	Initiated	BofA Securities	Buy	$41

Show Previous Ratings

Jul-14-25 02:46PM	Jim Cramer Notes Tempus AI is "Losing Money Hand Over Fist" (Insider Monkey)
11:11AM	Tempus AI Expands "Tempus Next" Platform to Improve Breast Cancer Care with AI-Driven Insights. (Insider Monkey)
Jul-10-25 12:00PM	Cathie Wood's ARK Loads Up on Tempus AI, Cuts Roku and Block (GuruFocus.com)
04:00AM	The early winner in the 'Dexit' war for corporate relocations: Nevada (Yahoo Finance)
Jul-09-25 08:55PM	Lightning Round: When it comes to AI, I believe in Nvidia, says Jim Cramer (CNBC TV)
04:00PM	Loading…
04:00PM	Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients (Business Wire)
Jul-08-25 08:30AM	Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer (Business Wire)
Jul-07-25 09:55AM	Tempus AI Boosts R&D Efforts Through Wide-Ranging Product Launches (Zacks)
08:27AM	Here's What Boosted Tempus AI (TEM) in Q1 (Insider Monkey)
08:06AM	TEM Securities Lawsuit Filed Against Tempus AI, Inc. Contact the DJS Law Group to Discuss Your Rights (PR Newswire)
Jul-05-25 12:22PM	Why Tempus AI Stock Soared 15.2% in June (Motley Fool)
Jul-04-25 08:43AM	Tempus AI Revenues & Profit Rise: What to Expect Ahead of Q2 Release (Zacks)
Jul-03-25 12:01PM	Hims & Hers Enhances Healthcare Through AI-Driven Personalization (Zacks)
Jul-02-25 10:28AM	Tempus AI (TEM) Falters on $400-Million Debt Issue (Insider Monkey)
08:11AM	What's Fueling Tempus AI's Explosive Sales Growth? (Zacks)
10:43PM	Loading…
Jun-30-25 10:43PM	Tempus Announces Pricing of Upsized Offering of $650 Million of Convertible Senior Notes (Business Wire) -6.44%
09:50AM	AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway (PR Newswire)
07:00AM	Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense (Business Wire)
02:42AM	Tempus AI's Ambry Genetics Leads with Validated 99.5% Accurate Hereditary Cancer Risk Assessment Tool (Insider Monkey)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-27-25 09:15AM	Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last? (Zacks)
Jun-25-25 05:00PM	Ambry Genetics CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing (Business Wire)
10:15AM	Agentic AI Market worth $140.80 billion by 2032- Exclusive Report by MarketsandMarkets (PR Newswire)
Jun-24-25 07:25PM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey)
Jun-23-25 03:00PM	TEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now? (Zacks)
Jun-20-25 08:41AM	Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building? (Zacks)
Jun-19-25 09:01AM	Biovica International AB (FRA:9II) Q4 2025 Earnings Call Highlights: Strategic Partnerships and ... (GuruFocus.com)
Jun-17-25 09:33AM	Members of Congress Are Pouring Millions Into These 7 Surprising Stocks (Motley Fool)
08:30AM	Tempus to Participate in TD Cowen's 4th Annual Tools/Dx Revolution Conference (Business Wire)
Jun-13-25 12:07PM	Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach (Zacks)
03:47PM	Loading…
Jun-12-25 03:47PM	Veteran analyst unveils bold price target for Tempus AI stock (TheStreet)
08:30AM	Tempus Announces Collaboration with Northwestern Universitys Abrams Research Center on Neurogenomics to Leverage AI for Alzheimers Disease Research (Business Wire)
Jun-09-25 03:00PM	Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? (Zacks) +7.85%
Jun-06-25 01:55PM	Why Shares of Tempus AI Are Jumping Higher This Week (Motley Fool) +5.81%
09:09AM	Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape? (Zacks)
04:41AM	Zacks Investment Ideas feature highlights: Tempus AI, SoundHound AI and Innodata (Zacks)
Jun-05-25 11:30AM	3 AI Stocks Flying Under the Radar (Zacks) -6.56%
11:07AM	Update! What Is Congress Trading So Far In 2025? (MarketBeat)
05:00AM	Zacks Investment Ideas feature highlights: Nvidia, Alphabet, Constellation Energy and Meta Platform (Zacks)
Jun-04-25 09:45AM	Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries (Zacks)
Jun-03-25 02:23AM	Why Tempus AI, Inc. (TEM) Skyrocketed On Monday (Insider Monkey)
Jun-02-25 05:22PM	Why Tempus AI Stock Soared 15% Today (Motley Fool) +15.02%
04:17PM	Tempus AI recovers 15% as Wall Street downplays Spruce Point allegations (Investing.com)
02:13PM	Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism (Yahoo Finance Video)
08:30AM	Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers (Business Wire)
Jun-01-25 02:33PM	Cathie Wood buys $13.9 million of popular AI stock (TheStreet)
08:30AM	Introducing Tempus One in the EHR with Integrated Guidelines (Business Wire)
May-31-25 01:33PM	Tempus AI hits back at scathing short report (TheStreet)
08:40AM	Tempus AI announces 10 abstracts accepted for presentation at 2025 ASCO meeting (TipRanks)
08:30AM	Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model (Business Wire)
May-30-25 11:23AM	Tempus AI Stock: Buy the Dip, or Is the Short-Seller Right? (Motley Fool)
10:06AM	Why Tempus AI Stock Plummeted This Week (Motley Fool)
09:09AM	Real-World Deployments Signal AI Healthcare Is Ready for Scale (PR Newswire)
08:30AM	Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting (Business Wire)
May-29-25 05:45AM	Why Tempus AI, Inc. (TEM) Went Down On Wednesday (Insider Monkey)
May-28-25 03:57PM	Tempus AI, Box earnings, Victoria's Secret: Trending Tickers (Yahoo Finance Video) -19.23%
02:32PM	A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today (Motley Fool)
02:08PM	Nvidia earnings, Tempus AI short, Vail Resorts CEO returns (Yahoo Finance Video)
12:41PM	Why Artificial Intelligence Stock Tempus AI Is Tumbling Today (Motley Fool)
09:10AM	Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Tempus AI, Inc. (Nasdaq: TEM) (Business Wire)
08:30AM	A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years (Business Wire)
May-27-25 06:15AM	New Study Shows Impact of Ambry Genetics Patient for Life Program on Rare Disease Diagnosis (Business Wire) +5.29%
May-26-25 03:00PM	Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy? (Zacks)
May-23-25 02:30AM	These Investors Search for Extreme Winners. Why Aurora, BYD, Tempus AI Make the Cut. (Barrons.com) +5.59%
May-21-25 12:57PM	Options Trading Now Available on Three Tradr ETFs: QBTX, TEMT and APPX (PR Newswire) -6.87%
08:48AM	Zacks Investment Ideas feature highlights: Palantir, Tempus AI and Comfort Systems USA (Zacks)
08:30AM	Tempus to Present at the William Blair 45th Annual Growth Stock Conference (Business Wire)
May-20-25 11:39AM	Tempus partners with Verastem for companion diagnostic development (Medical Device Network)
11:15AM	These 3 AI-Related Stocks Crushed Earnings (Zacks)
08:30AM	Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment (Business Wire)
07:33AM	From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room (PR Newswire)
May-19-25 11:16AM	Should You be Confident in Tempus AI (TEM)? (Insider Monkey)
May-15-25 03:00PM	After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? (Zacks)
04:48AM	Boehringer partners Tempus AI to enhance cancer therapy pipeline (Pharmaceutical Technology)
May-14-25 08:30AM	Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline (Business Wire) -5.99%
May-13-25 07:40PM	Why Tempus AI Inc. (TEM) Skyrocketed On Tuesday (Insider Monkey) +9.92%
04:05PM	Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025 (Business Wire)
11:34AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (and Sold) (Motley Fool)
11:11AM	Is Tempus AI, Inc. (TEM) the Best Performing Healthcare Stock to Buy Now? (Insider Monkey)
06:45AM	Tradr Launches First Leveraged ETF on Tempus AI (PR Newswire)
May-10-25 09:50AM	Jim Cramer Says Stay Away from This Nancy Pelosi Stock (Insider Monkey)
07:00AM	MarketBeat Week in Review - 05/05 - 05/09 (MarketBeat)
May-09-25 11:30AM	These AI Stocks Posted Robust Results: Time to Buy? (Zacks) -5.90%
May-08-25 07:45AM	Tempus AI Stock: Time to Double Down or Cut and Run? (MarketBeat) +10.99%
01:48AM	Why Tempus AI, Inc. (TEM) Skyrocketed On Wednesday (Insider Monkey)
May-07-25 12:34PM	Q1 2025 Tempus AI Inc Earnings Call (Thomson Reuters StreetEvents) +12.59%
07:49AM	Tempus AI, Inc. (TEM): Among Most Popular Stocks on Robinhood in 2025 (Insider Monkey)
03:22AM	Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
May-06-25 04:01PM	Tempus Reports First Quarter 2025 Results (Business Wire)
May-05-25 05:07PM	Jim Cramer Warns on Tempus AI (TEM): "Diagnostics With no Dough? I'm Out" (Insider Monkey) -5.24%
12:35PM	AI Healthcare Boom Gains Speed as Regulators and Innovators Align (PR Newswire)
08:30AM	Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry (Business Wire)
May-02-25 08:58AM	Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. (Motley Fool) +10.05%
05:32AM	Tempus selects TIME Network for Phase I clinical trials (Clinical Trials Arena)
May-01-25 11:04AM	New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty (PR Newswire)
08:30AM	Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment (Business Wire)
Apr-30-25 05:32AM	Is This the Best Nancy Pelosi Stock to Buy After a 40% Pullback? (Motley Fool)
Apr-29-25 08:45AM	Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth (GlobeNewswire)
08:30AM	Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection (Business Wire)
Apr-28-25 03:00PM	Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? (Zacks)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fukushima Ryan	Chief Operating Officer	Jul 07 '25	Sale	60.00	5,000	300,000	145,000	Jul 09 04:15 PM
VANESSA L KUBO	Officer	Jul 07 '25	Proposed Sale	60.97	20,000	1,219,400		Jul 07 04:16 PM
Doudna Jennifer A	Director	Jul 01 '25	Sale	62.52	625	39,075	26,554	Jul 03 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 17 '25	Sale	70.07	250,000	17,516,593	9,357,283	Jun 20 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 18 '25	Sale	69.44	250,000	17,359,469	9,307,283	Jun 20 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Jun 16 '25	Sale	72.56	51,317	3,723,634	97,779	Jun 18 04:15 PM
Polovin Andrew	EVP and General Counsel	Jun 16 '25	Sale	72.13	1,423	102,641	137,454	Jun 18 04:15 PM
Eric Paul Lefkofsky	Officer	Jun 17 '25	Proposed Sale	72.00	400,000	28,800,000		Jun 17 09:45 PM
ERIK PHELPS	Officer	Jun 16 '25	Proposed Sale	71.28	51,317	3,657,876		Jun 16 04:30 PM
ANDREW POLOVIN	Officer	Jun 16 '25	Proposed Sale	71.28	1,423	101,431		Jun 16 04:22 PM
Leonsis Theodore	Director	Jun 11 '25	Sale	67.66	205,847	13,927,976	0	Jun 13 04:15 PM
Revolution Growth Management C	Shareholder	Jun 11 '25	Proposed Sale	69.38	205,847	14,281,665		Jun 11 04:02 PM
Fukushima Ryan	Chief Operating Officer	Jun 03 '25	Sale	62.29	20,000	1,245,764	856,640	Jun 05 04:15 PM
Doudna Jennifer A	Director	Jun 02 '25	Sale	55.20	558	30,802	27,179	Jun 04 04:15 PM
Epstein David R	Director	Jun 02 '25	Sale	55.20	250	13,800	27,661	Jun 04 04:15 PM
JENNIFER A DOUDNA	Director	Jun 02 '25	Proposed Sale	55.18	1,183	65,278		Jun 02 04:32 PM
Rogers James William	Chief Financial Officer	May 20 '25	Sale	63.27	23,121	1,462,809	146,001	May 22 08:00 PM
Polovin Andrew	EVP and General Counsel	May 20 '25	Sale	63.43	17,552	1,113,385	138,877	May 22 08:00 PM
Phelps Erik	EVP & Chief Admin & Legal Off	May 20 '25	Sale	63.21	8,415	531,918	149,096	May 22 08:00 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 20 '25	Sale	63.21	16,752	1,058,905	4,878,837	May 22 08:00 PM
Fukushima Ryan	Chief Operating Officer	May 20 '25	Sale	63.21	7,820	494,308	876,640	May 22 08:00 PM
Bartolucci Ryan M	Chief Accounting Officer	May 20 '25	Sale	63.23	6,073	384,023	47,799	May 22 08:00 PM
Ryan M. Bartolucci	Officer	May 20 '25	Proposed Sale	63.74	4,254	271,150		May 21 07:39 PM
Ryan Fukushima	Officer	May 20 '25	Proposed Sale	63.74	7,820	498,447		May 21 07:36 PM
Andrew Polovin	Officer	May 20 '25	Proposed Sale	63.74	9,797	624,461		May 21 07:25 PM
Eric Paul Lefkofsky	Officer	May 20 '25	Proposed Sale	63.74	16,752	1,067,772		May 21 07:23 PM
Erik Phelps	Officer	May 20 '25	Proposed Sale	63.74	8,415	536,372		May 21 07:20 PM
James William Rogers	Officer	May 20 '25	Proposed Sale	63.74	11,413	727,465		May 21 07:18 PM
RYAN BARTOLUCCI	Officer	May 20 '25	Proposed Sale	63.74	1,819	115,943		May 20 04:32 PM
ANDREW POLOVIN	Officer	May 20 '25	Proposed Sale	63.74	7,755	494,304		May 20 04:31 PM
JAMES ROGERS	Officer	May 20 '25	Proposed Sale	63.74	11,708	746,268		May 20 04:31 PM
Leonsis Theodore	Director	May 09 '25	Sale	66.26	770	51,020	43,550	May 13 04:15 PM
REVOLUTION GROWTH III, LP	Shareholder	May 09 '25	Proposed Sale	65.22	770	50,219		May 09 04:18 PM
Fukushima Ryan	Chief Operating Officer	May 06 '25	Sale	52.36	20,000	1,047,239	884,460	May 08 04:30 PM
Epstein David R	Director	May 01 '25	Sale	53.50	370	19,795	25,914	May 05 04:15 PM
Gottlieb Scott	Director	Apr 01 '25	Sale	47.21	27,837	1,314,154	32,839	Apr 03 05:30 PM
Doudna Jennifer A	Director	Apr 01 '25	Sale	48.12	625	30,075	25,740	Apr 03 04:15 PM
Fukushima Ryan	Chief Operating Officer	Apr 01 '25	Sale	47.20	20,000	944,085	904,460	Apr 03 04:15 PM
Frederick Wayne A.I.	Director	Mar 31 '25	Sale	45.54	3,000	136,620	26,514	Apr 02 06:13 PM
RYAN FUKUSHIMA	Officer	Apr 01 '25	Proposed Sale	48.24	60,000	2,894,400		Apr 01 04:22 PM
Polovin Andrew	EVP and General Counsel	Mar 21 '25	Sale	50.00	3,076	153,800	151,095	Mar 25 04:15 PM
ANDREW POLOVIN	Officer	Mar 21 '25	Proposed Sale	48.04	3,076	147,771		Mar 21 04:21 PM
Rogers James William	Chief Financial Officer	Mar 18 '25	Sale	45.97	23,030	1,058,699	164,750	Mar 19 06:30 PM
Polovin Andrew	EVP and General Counsel	Mar 18 '25	Sale	45.98	13,135	603,970	154,171	Mar 19 06:30 PM
Epstein David R	Director	Mar 17 '25	Sale	46.83	990	46,362	26,284	Mar 19 06:30 PM
West Nadja	Director	Mar 17 '25	Sale	48.86	7,634	372,962	30,071	Mar 19 06:30 PM
Gottlieb Scott	Director	Mar 17 '25	Sale	48.85	27,838	1,359,989	60,676	Mar 19 06:30 PM
Frederick Wayne A.I.	Director	Mar 17 '25	Sale	48.85	9,000	439,659	29,514	Mar 19 06:30 PM
Doudna Jennifer A	Director	Mar 17 '25	Sale	48.80	9,308	454,210	26,365	Mar 19 06:30 PM
ANDREW POLOVIN	Officer	Mar 18 '25	Proposed Sale	49.87	13,135	655,042		Mar 18 04:41 PM
JAMES ROGERS	Officer	Mar 18 '25	Proposed Sale	49.87	23,030	1,148,506		Mar 18 04:27 PM
WAYNE FREDERICK	Director	Mar 17 '25	Proposed Sale	47.17	12,000	566,040		Mar 17 04:47 PM
DAVID R. EPSTEIN	Director	Mar 17 '25	Proposed Sale	47.17	1,610	75,944		Mar 17 04:25 PM
SCOTT GOTTLIEB	Director	Mar 17 '25	Proposed Sale	47.17	55,675	2,626,190		Mar 17 04:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 05 '25	Sale	50.93	562,345	28,641,725	9,457,283	Mar 07 04:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 06 '25	Sale	49.83	250,000	12,457,454	9,407,283	Mar 07 04:56 PM
Fukushima Ryan	Chief Operating Officer	Mar 04 '25	Sale	51.15	20,000	1,022,974	924,460	Mar 06 05:05 PM
West Nadja	Director	Mar 04 '25	Sale	51.11	809	41,347	37,705	Mar 06 05:05 PM
Eric P. Lefkofsky	Officer	Mar 05 '25	Proposed Sale	52.73	662,345	34,925,452		Mar 05 05:44 PM
Doudna Jennifer A	Director	Mar 03 '25	Sale	57.52	338	19,442	35,673	Mar 05 04:15 PM
Epstein David R	Director	Mar 03 '25	Sale	57.52	250	14,380	27,274	Mar 05 04:15 PM
NADJA WEST	Director	Mar 04 '25	Proposed Sale	50.93	8,443	430,002		Mar 04 05:08 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 27 '25	Sale	58.75	3,240,234	190,363,748	0	Feb 27 07:39 PM
Lightbank Investments 1B, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	115,751	6,840,884		Feb 27 04:27 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,580,928	93,432,845		Feb 27 04:26 PM
Lightbank Global, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,397,589	82,597,510		Feb 27 04:25 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	145,966	8,626,591		Feb 27 04:24 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '25	Sale	80.87	84,640	6,844,680	4,964,820	Feb 20 07:55 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 20 '25	Sale	74.09	69,231	5,129,325	4,895,589	Feb 20 07:55 PM
Fukushima Ryan	Chief Operating Officer	Feb 19 '25	Sale	81.87	2,868	234,814	944,460	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 20 '25	Sale	80.00	1,682	134,560	44,500	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 19 '25	Sale	81.87	818	66,973	46,182	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 18 '25	Sale	82.36	61,582	5,072,077	153,080	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 19 '25	Sale	81.87	903	73,932	152,177	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 18 '25	Sale	82.32	64,381	5,299,820	172,857	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 19 '25	Sale	81.87	5,551	454,470	167,306	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 18 '25	Sale	82.33	31,780	2,616,308	189,320	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 19 '25	Sale	81.87	1,540	126,086	187,780	Feb 20 07:55 PM
RYAN BARTOLUCCI	Officer	Feb 20 '25	Proposed Sale	85.71	1,682	144,164		Feb 20 04:22 PM
JAMES ROGERS	Officer	Feb 18 '25	Proposed Sale	89.44	31,780	2,842,403		Feb 18 04:29 PM
ANDREW POLOVIN	Officer	Feb 18 '25	Proposed Sale	89.44	64,381	5,758,237		Feb 18 04:29 PM
ERIK PHELPS	Officer	Feb 18 '25	Proposed Sale	89.44	61,582	5,507,894		Feb 18 04:28 PM
Doudna Jennifer A	Director	Feb 14 '25	Sale	90.00	1,320	118,800	36,011	Feb 14 07:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 14 '25	Sale	85.78	80,003	6,862,467	5,049,460	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 13 '25	Sale	78.51	78,594	6,170,792	5,129,463	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 12 '25	Sale	70.02	84,948	5,948,059	5,208,057	Feb 14 04:33 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 13 '25	Sale	80.00	6,059	484,720	47,000	Feb 14 04:32 PM
JENNIFER A DOUDNA	Director	Feb 14 '25	Proposed Sale	83.75	11,253	942,439		Feb 14 04:23 PM
RYAN BARTOLUCCI	Officer	Feb 13 '25	Proposed Sale	73.88	6,059	447,639		Feb 13 04:31 PM
LEFKOFSKY ERIC P	Officer	Feb 12 '25	Proposed Sale	71.21	535,000	38,097,350		Feb 12 08:21 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 05 '25	Sale	67.57	5,934	400,960	214,662	Feb 07 05:38 PM
Polovin Andrew	EVP and General Counsel	Feb 05 '25	Sale	67.57	7,717	521,438	237,238	Feb 07 05:36 PM
Rogers James William	Chief Financial Officer	Feb 05 '25	Sale	67.57	8,712	588,670	221,100	Feb 07 05:35 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 06 '25	Sale	71.00	2,320	164,720	53,059	Feb 07 05:34 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 05 '25	Sale	67.57	1,858	125,545	55,379	Feb 07 05:34 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 06 '25	Sale	67.89	85,109	5,778,114	5,373,393	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 07 '25	Sale	67.53	80,388	5,428,398	5,293,005	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 05 '25	Sale	67.53	74,485	5,030,067	5,458,502	Feb 07 05:33 PM
Fukushima Ryan	Chief Operating Officer	Feb 04 '25	Sale	62.50	20,000	1,250,033	962,442	Feb 06 06:02 PM
Fukushima Ryan	Chief Operating Officer	Feb 05 '25	Sale	67.57	15,114	1,021,253	947,328	Feb 06 06:02 PM

Open in Screener

PODD

Insulet Corporation

Jul 14 • 04:00PM ET

292.01

Dollar change +2.69
Percentage change 0.93	%

Healthcare • Medical Devices • USA • NASD

PODD Insulet Corporation daily Stock Chart

Peers: DXCM JNJ ABT MDT EW SYK TNDM BSX BAX LIVN

| Held by: VTI VOO VB VO SPY IVV VUG VBK XLV RSP

Index	S&P 500	P/E	52.55	EPS (ttm)	5.56	Insider Own	0.51%	Shs Outstand	70.36M	Perf Week	-2.89%
Market Cap	20.55B	Forward P/E	53.78	EPS next Y	5.43	Insider Trans	-8.15%	Shs Float	70.02M	Perf Month	-3.38%
Enterprise Value	20.96B	PEG	1.90	EPS next Q	0.92	Inst Own	102.17%	Short Float	3.16%	Perf Quarter	16.12%
Income	402.20M	P/S	9.35	EPS this Y	34.30%	Inst Trans	0.55%	Short Ratio	2.68	Perf Half Y	8.01%
Sales	2.20B	P/B	15.44	EPS next Y	24.77%	ROA	13.10%	Short Interest	2.21M	Perf YTD	11.85%
Book/sh	18.91	P/C	16.02	EPS next 5Y	27.68%	ROE	37.92%	52W High	329.33 -11.33%	Perf Year	47.73%
Cash/sh	18.23	P/FCF	70.52	EPS past 3/5Y	186.88% 98.82%	ROIC	13.67%	52W Low	173.00 68.79%	Perf 3Y	24.20%
Dividend Est.	-	EV/EBITDA	48.28	Sales past 3/5Y	23.54% 22.92%	Gross Margin	71.14%	Volatility	2.05% 2.28%	Perf 5Y	41.66%
Dividend TTM	-	EV/Sales	9.53	EPS Y/Y TTM	71.25%	Oper. Margin	15.50%	ATR (14)	7.29	Perf 10Y	883.20%
Dividend Ex-Date	-	Quick Ratio	3.59	Sales Y/Y TTM	23.49%	Profit Margin	18.29%	RSI (14)	38.74	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	4.43	EPS Q/Q	-31.57%	SMA20	-3.60%	Beta	1.36	Target Price	343.17
Payout	0.00%	Debt/Eq	1.27	Sales Q/Q	28.82%	SMA50	-4.20%	Rel Volume	0.73	Prev Close	289.32
Employees	3900	LT Debt/Eq	1.21	Earnings	Aug 07 BMO	SMA200	7.94%	Avg Volume	827.33K	Price	292.01
IPO	May 15, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.11% 4.73%	Trades		Volume	605,758	Change	0.93%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	Truist	Buy	$365
May-30-25	Initiated	Goldman	Buy	$380
May-13-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$350
Apr-29-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Mar-06-25	Initiated	RBC Capital Mkts	Outperform	$340
Nov-06-24	Initiated	Bernstein	Outperform	$300
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265
Aug-21-23	Downgrade	Robert W. Baird	Outperform → Neutral	$320 → $219
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$343
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$235 → $340
Oct-18-22	Initiated	Barclays	Equal Weight	$238
Oct-12-22	Initiated	Jefferies	Hold	$260
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$310 → $250
Mar-02-22	Resumed	BofA Securities	Buy	$300

Show Previous Ratings

Jul-11-25 08:12PM	Analyst Report: Insulet Corporation (Morningstar Research)
Jul-09-25 02:33PM	Semler Scientific Stock Gets Relative Strength Rating Upgrade (Investor's Business Daily)
12:10PM	Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-08-25 06:00AM	Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire)
Jul-01-25 04:04PM	Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids (Investor's Business Daily)
12:16PM	Loading…
12:16PM	Apple AI, Wolfspeed bankruptcy, medical device stocks (Yahoo Finance Video)
09:59AM	Medical device maker stocks falls after proposed Medicare payment cuts (Investing.com)
Jun-30-25 06:19AM	5 Insightful Analyst Questions From Insulet's Q1 Earnings Call (StockStory)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-25-25 12:15PM	Diabetes stocks rally after RFK comments on HHS campaign (TipRanks)
Jun-24-25 08:54AM	How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? (Barchart)
Jun-19-25 06:00AM	Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions (Business Wire)
Jun-17-25 09:35AM	Cisco upgraded, CoreWeave downgraded: Wall Streets top analyst calls (TipRanks)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-11-25 09:51AM	Here's Why You Should Retain PODD Stock in Your Portfolio Now (Zacks)
08:30AM	Loading…
Jun-10-25 08:30AM	Insulets Omnipod 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users (Business Wire)
04:36AM	PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption (StockStory)
Jun-09-25 07:29AM	3 Medical Technology Stocks Outperforming in 2025 (MarketBeat)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
Jun-05-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
12:01AM	3 Reasons Investors Love Insulet (PODD) (StockStory)
Jun-04-25 11:33PM	Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks (StockStory)
09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Jun-03-25 11:30AM	S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF (Zacks)
Jun-02-25 03:18PM	Solventum Stock Earns RS Rating Upgrade (Investor's Business Daily)
May-30-25 10:17AM	Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy (Investing.com)
May-26-25 08:30AM	Insulet Gains 78.5% in a Year: What's Driving the Stock? (Zacks)
May-23-25 06:01AM	Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Business Wire)
May-22-25 09:36AM	Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies (Zacks)
May-21-25 11:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
09:50AM	Loading…
May-16-25 09:50AM	Here's Why Insulet (PODD) is a Strong Momentum Stock (Zacks)
05:51AM	Dexcom CEO says CGMs fit MAHA agenda very nicely; Tandem preps for new products (MedTech Dive)
May-15-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
May-14-25 12:45PM	Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today (Insider Monkey)
08:45AM	Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer (MarketBeat)
07:20AM	Outlier Money Flows Lift Insulet (FX Empire)
May-13-25 06:00AM	Insulet Announces Publication of 2024 Sustainability Report (Business Wire)
May-12-25 09:10AM	Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised (Zacks)
May-10-25 11:47AM	S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points (Investor's Business Daily)
May-09-25 08:41PM	Analyst Report: Insulet Corporation (Morningstar Research) +20.88%
05:49PM	S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks (Investopedia)
05:49PM	S&P 500 Gains & Losses Today: Index Pulls Back Early Gains Amid Anticipation of Trade Talks (Investopedia)
04:02PM	Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops (Investor's Business Daily)
02:37PM	Insulet Stock Soars to Lead S&P 500 Gainers Friday (Investopedia)
02:16PM	Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops (Yahoo Finance Video)
11:57AM	Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More (Investopedia)
11:29AM	New Insulet CEO Ashley McEvoy sets priorities (MedTech Dive)
10:11AM	Insulet Stock Is the Top S&P 500 Performer Today. Heres Why. (Barrons.com)
08:21AM	Q1 2025 Insulet Corp Earnings Call (Thomson Reuters StreetEvents)
03:39AM	Insulet Corp (PODD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion (GuruFocus.com)
May-08-25 07:01PM	Analyst Report: Insulet Corporation (Morningstar Research)
05:30PM	Insulet (PODD) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates (Zacks)
04:11PM	Insulet Makes A Bullish Post-Earnings Move With A Beat-And-Raise (Investor's Business Daily)
04:11PM	Insulet Jumps After Beating Quarterly Forecasts, Raising 2025 Expectations (Investor's Business Daily)
04:10PM	Insulet: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1) (Business Wire)
May-07-25 05:20PM	Insulet Q1 2025 Earnings Preview (Seeking Alpha)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-05-25 09:15AM	Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
12:33AM	1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About (StockStory)
Apr-29-25 09:30PM	Franklin Convertible Securities Fund Q1 2025 Commentary (Seeking Alpha)
Apr-28-25 10:00AM	Insulet Names New CEO, Expects to Top Revenue Projections (Investopedia)
09:06AM	Ashley McEvoy named Insulet CEO (MedTech Dive)
09:04AM	1 Healthcare Stock Worth Your Attention and 2 to Turn Down (StockStory)
06:00AM	Insulet Appoints Ashley McEvoy President and CEO (Business Wire)
Apr-17-25 08:52AM	4 Medical Product Stocks to Buy From a Challenging Industry (Zacks)
Apr-14-25 12:18PM	International Growth Drives GMED Stock Amid Fierce Competition (Zacks)
08:24AM	Bruker Stock May Benefit Following Its Investment in Ridom GmbH (Zacks)
Apr-13-25 08:38AM	Oakmark Bond Fund Q1 2025 Commentary (Seeking Alpha)
Apr-11-25 10:01AM	Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? (Zacks)
Apr-10-25 05:17AM	Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength? (Zacks) -5.01%
Apr-09-25 08:09AM	5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout (Zacks) +7.16%
Apr-08-25 11:55AM	Oakmark Fixed Income Market Q1 2025 Commentary (Seeking Alpha)
10:02AM	PODD Stock Benefits From the Launch of Omnipod 5 in Canada (Zacks)
Apr-07-25 01:34PM	This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength (Investor's Business Daily)
07:07AM	Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above (PR Newswire)
Apr-03-25 02:25PM	Analyst Report: Insulet Corporation (Morningstar Research)
06:00AM	Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
Mar-31-25 09:30AM	DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes (Zacks)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-27-25 10:50AM	Columbia Select Large Cap Growth Fund Q4 2024 Commentary (SeekingAlpha)
05:14AM	3 Reasons Investors Love Insulet (PODD) (StockStory)
Mar-24-25 08:09AM	Insulet Gains 62.9% in a Year: What's Driving the Stock? (Zacks)
Mar-21-25 12:36PM	PODD Stock Gains Following the Launch of Omnipod 5 in Australia (Zacks)
08:30AM	Artisan International Small-Mid Fund Q4 2024 Commentary (SeekingAlpha)
08:19AM	DGX Stock Set to Benefit From New Google Cloud Partnership (Zacks)
05:06AM	Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers (StockStory)
Mar-20-25 12:41PM	PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5 (Zacks)
08:23AM	LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:54AM	Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data (MedTech Dive)
Mar-19-25 04:01PM	Insulets RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections (Business Wire)
11:03AM	3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan (Zacks)
Mar-18-25 04:32PM	Insulet Announces Pricing of Senior Notes Due 2033 (Business Wire)
01:51PM	Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires (Insider Monkey)
10:35AM	Insulet Chief Technology Officer Mark Field leaves (MedTech Dive)
07:35AM	Insulet Announces Proposed Financing Transactions (Business Wire)
06:05AM	Insulet Expands Omnipod 5 to Four More International Markets (Business Wire)
06:00AM	From Injections to Innovation Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod 5 in Adults and Children with Type 1 Diabetes (Business Wire)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singh Prem	SVP, Global Operations	Jun 13 '25	Option Exercise	166.62	1,257	209,441	6,470	Jun 16 04:18 PM
Singh Prem	SVP, Global Operations	Jun 13 '25	Sale	300.05	2,327	698,216	4,143	Jun 16 04:18 PM
Manea Dan	SVP, Chief HR Officer	Jun 13 '25	Sale	300.05	1,300	390,065	9,090	Jun 16 04:16 PM
Singh Prem	Officer	Jun 13 '25	Proposed Sale	300.05	2,327	698,216		Jun 13 10:15 AM
Manea Dan	Officer	Jun 13 '25	Proposed Sale	300.05	1,300	390,065		Jun 13 09:45 AM
BORIO LUCIANA	Director	Jun 09 '25	Sale	305.73	481	147,056	3,087	Jun 10 04:17 PM
BORIO LUCIANA	Director	Jun 09 '25	Proposed Sale	305.72	481	147,054		Jun 09 01:08 PM
Hollingshead James	Former Officer	May 16 '25	Proposed Sale	323.10	15,605	5,041,964		May 16 04:40 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Option Exercise	95.43	5,278	503,680	28,458	May 15 04:25 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Sale	318.47	5,278	1,680,885	23,180	May 15 04:25 PM
Hopfield Jessica	Director	May 13 '25	Option Exercise	28.87	5,235	151,134	32,152	May 14 04:15 PM
Hopfield Jessica	Director	May 13 '25	Sale	317.54	5,235	1,662,322	26,917	May 14 04:15 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Option Exercise	92.11	3,001	276,422	23,907	May 14 04:08 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Sale	320.00	3,001	960,320	20,906	May 14 04:08 PM
Kapples John W.	Officer	May 14 '25	Proposed Sale	318.47	5,278	1,680,901		May 14 12:32 PM
Field Mark N	Former Officer	May 13 '25	Proposed Sale	321.31	2,457	789,459		May 13 01:44 PM
Benjamin Eric	Officer	May 13 '25	Proposed Sale	320.00	3,001	960,320		May 13 12:51 PM
Hopfield Jessica	Director	May 13 '25	Proposed Sale	317.54	5,235	1,662,322		May 13 10:19 AM
Frederick Wayne A.I.	Director	Mar 25 '25	Sale	275.00	1,825	501,875	3,231	Mar 26 04:22 PM
Frederick Wayne A.I.	Director	Mar 25 '25	Proposed Sale	275.00	1,825	501,875		Mar 25 10:30 AM
Benjamin Eric	EVP, CPXO	Mar 03 '25	Option Exercise	56.52	5,146	290,873	20,906	Mar 04 04:09 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Option Exercise	65.00	5,075	329,898	23,777	Jan 22 04:10 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Sale	280.00	12,394	3,470,320	11,383	Jan 22 04:10 PM
Benjamin Eric	Officer	Jan 21 '25	Proposed Sale	280.00	12,394	3,470,320		Jan 21 10:56 AM
Benjamin Eric	EVP, CPXPO	Dec 16 '24	Sale	267.60	4,362	1,167,271	18,702	Dec 17 04:14 PM
Benjamin Eric	Officer	Dec 16 '24	Proposed Sale	267.60	4,362	1,167,271		Dec 16 10:38 AM
Budden Lauren	Group VP, CAO and Controller	Dec 10 '24	Sale	275.62	915	252,192	5,733	Dec 11 04:00 PM
Budden Lauren	Officer	Dec 10 '24	Proposed Sale	275.62	915	252,194		Dec 10 05:18 PM
BORIO LUCIANA	Director	Nov 12 '24	Sale	274.80	508	139,598	2,790	Nov 13 04:01 PM
BORIO LUCIANA	Director	Nov 12 '24	Proposed Sale	274.81	508	139,602		Nov 12 04:01 PM
Hopfield Jessica	Director	Sep 11 '24	Option Exercise	29.87	7,628	227,848	34,545	Sep 12 04:07 PM
Hopfield Jessica	Director	Sep 11 '24	Sale	225.26	7,628	1,718,283	26,917	Sep 12 04:07 PM
Scannell Timothy J	Director	Sep 10 '24	Sale	225.84	5,000	1,129,200	30,586	Sep 11 04:13 PM
Hopfield Jessica	Director	Sep 11 '24	Proposed Sale	225.26	7,628	1,718,283		Sep 11 03:40 PM
Field Mark N	SVP & Chief Technology Officer	Sep 09 '24	Sale	220.87	1,383	305,463	9,761	Sep 10 04:16 PM
Budden Lauren	Group VP, CAO and Controller	Sep 09 '24	Sale	221.41	1,506	333,443	6,609	Sep 10 04:15 PM
Scannell Timothy J	Director	Sep 10 '24	Proposed Sale	225.84	5,000	1,129,210		Sep 10 02:27 PM
Field Mark N	Officer	Sep 09 '24	Proposed Sale	220.87	1,383	305,465		Sep 09 04:50 PM
Budden Lauren	Officer	Sep 09 '24	Proposed Sale	221.41	1,506	333,436		Sep 09 01:20 PM
Singh Prem	SVP, Global Operations	Aug 30 '24	Sale	202.27	1,824	368,940	3,656	Sep 03 04:30 PM
Singh Prem	Officer	Aug 30 '24	Proposed Sale	202.27	1,824	368,938		Aug 30 03:22 PM
Chadwick Ana Maria	EVP, CFO & Treasurer	Aug 29 '24	Buy	206.00	100	20,600	13,314	Aug 29 04:17 PM
Field Mark N	SVP & Chief Technology Officer	Aug 28 '24	Sale	203.00	1,387	281,561	11,347	Aug 29 04:14 PM
Field Mark N	Officer	Aug 28 '24	Proposed Sale	203.00	1,387	281,561		Aug 28 04:02 PM

Open in Screener

WDAY

Workday Inc

Jul 14 • 04:00PM ET

224.76

Dollar change +1.39
Percentage change 0.62	%

Technology • Software - Application • USA • NASD

Peers: MSFT CRM ADBE ORCL NOW SAP INTU PAYC TEAM ZS

| Held by: VTI VOO QQQ VUG SPY IVV XLK VGT IWF IGV

Index	NDX, S&P 500	P/E	124.11	EPS (ttm)	1.81	Insider Own	19.69%	Shs Outstand	215.60M	Perf Week	-6.82%
Market Cap	60.01B	Forward P/E	22.06	EPS next Y	10.19	Insider Trans	-1.60%	Shs Float	214.43M	Perf Month	-10.58%
Enterprise Value	55.42B	PEG	7.29	EPS next Q	2.11	Inst Own	73.87%	Short Float	3.27%	Perf Quarter	0.01%
Income	487.00M	P/S	6.92	EPS this Y	20.30%	Inst Trans	0.06%	Short Ratio	3.30	Perf Half Y	-11.75%
Sales	8.67B	P/B	6.72	EPS next Y	16.00%	ROA	2.94%	Short Interest	7.02M	Perf YTD	-12.89%
Book/sh	33.46	P/C	7.51	EPS next 5Y	17.02%	ROE	5.70%	52W High	294.00 -23.55%	Perf Year	0.75%
Cash/sh	29.91	P/FCF	25.84	EPS past 3/5Y	156.63% -	ROIC	3.99%	52W Low	199.81 12.49%	Perf 3Y	52.28%
Dividend Est.	-	EV/EBITDA	58.58	Sales past 3/5Y	17.81% 18.37%	Gross Margin	75.56%	Volatility	2.47% 2.10%	Perf 5Y	17.31%
Dividend TTM	-	EV/Sales	6.39	EPS Y/Y TTM	-67.58%	Oper. Margin	7.05%	ATR (14)	5.83	Perf 10Y	193.11%
Dividend Ex-Date	-	Quick Ratio	2.01	Sales Y/Y TTM	15.38%	Profit Margin	5.62%	RSI (14)	31.49	Recom	1.73
Dividend Gr. 3/5Y	- -	Current Ratio	2.01	EPS Q/Q	-36.45%	SMA20	-5.36%	Beta	1.24	Target Price	298.09
Payout	0.00%	Debt/Eq	0.38	Sales Q/Q	12.61%	SMA50	-9.50%	Rel Volume	0.99	Prev Close	223.37
Employees	20400	LT Debt/Eq	0.37	Earnings	May 22 AMC	SMA200	-10.29%	Avg Volume	2.13M	Price	224.76
IPO	Oct 12, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.08% 1.00%	Trades		Volume	2,113,949	Change	0.62%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-25	Downgrade	Piper Sandler	Neutral → Underweight	$235
Feb-27-25	Reiterated	BMO Capital Markets	Outperform	$300 → $314
Feb-19-25	Initiated	Redburn Atlantic	Neutral
Feb-19-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$330 → $275
Jan-08-25	Upgrade	Deutsche Bank	Hold → Buy	$265 → $300
Jan-06-25	Upgrade	Guggenheim	Sell → Neutral
Nov-27-24	Downgrade	Piper Sandler	Overweight → Neutral	$285 → $270
Nov-19-24	Initiated	Scotiabank	Sector Outperform	$340
May-24-24	Reiterated	BMO Capital Markets	Outperform	$338 → $300
Feb-27-24	Reiterated	Needham	Buy	$300 → $350
Jan-10-24	Resumed	DA Davidson	Neutral	$300
Jan-04-24	Resumed	KeyBanc Capital Markets	Overweight	$310
Nov-29-23	Reiterated	BMO Capital Markets	Outperform	$260 → $290
Aug-25-23	Reiterated	Needham	Buy	$220 → $250
Jun-28-23	Initiated	RBC Capital Mkts	Outperform	$275
May-24-23	Upgrade	Exane BNP Paribas	Neutral → Outperform	$235
May-08-23	Downgrade	Stifel	Buy → Hold	$210 → $200
Mar-01-23	Downgrade	Societe Generale	Buy → Hold	$212 → $205
Feb-28-23	Reiterated	Wells Fargo	Overweight	$240 → $250
Feb-28-23	Reiterated	Stifel	Buy	$185 → $210

Show Previous Ratings

Jul-14-25 04:54PM	Tech, Media & Telecom Roundup: Market Talk (The Wall Street Journal)
09:15AM	Seattle University Chooses Workday to Power its Future-Ready Campus for Students and Staff (PR Newswire)
Jul-13-25 11:17AM	Workday (WDAY) Just Got Downgraded-Here's Why Analysts Are Worried About AI (Insider Monkey)
Jul-11-25 03:18PM	Indeed, Glassdoor cutting about 6% of staff; sites to merge operations (USA TODAY)
Jul-10-25 11:26PM	Analyst Sees Strong Growth Pipeline for Workday (WDAY) Amid Healthy Enterprise Demand (Insider Monkey)
05:50PM	Loading…
05:50PM	Workday (WDAY) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
11:58AM	Autodesk & PTC, Workday, Estée Lauder: Trending Tickers (Yahoo Finance Video)
11:06AM	Piper Sandler raises Oracle, cuts Workday as AI reshapes CIO spending priorities (Investing.com)
09:42AM	Nvidia initiated, Roku upgraded: Wall Street's top analyst calls (The Fly)
09:00AM	Simpplr Completes Workday Design Badge Integration (PR Newswire)
Jul-09-25 09:15AM	New Workday Report: Unmanaged Contracts Result in Significant Financial Losses and Undiscovered Business Value (PR Newswire)
09:00AM	Rain Launches Embedded Earned Wage Access Solution Within Workday (Business Wire)
Jul-08-25 08:00AM	Randstad Digital Named Workday Deployment Partner, Bringing Global Scale and Domain Expertise to Enterprise Clients (PR Newswire)
Jul-07-25 09:00AM	Payslip leads as first Workday partner on Global Payroll Connect, delivering 82% time savings (PR Newswire)
Jul-02-25 01:55PM	GQR Partners with Turbin.ai to Launch Workday Talent Marketplace (PR Newswire)
08:33AM	Loading…
08:33AM	Workday (WDAY) Fell Due to a Reduction in 2025 Revenue Guidance (Insider Monkey)
06:00AM	Semos Cloud Named Workday Innovation Partner (PR Newswire)
Jul-01-25 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
06:00AM	Syssero Launches SyncStream App to Help Simplify M&A Data Migration, Now Available on Workday Marketplace (GlobeNewswire)
Jun-30-25 04:46PM	Next-gen procurement platform Levelpath nabs $55M (TechCrunch)
06:35AM	Order.co Names Larry Robinett to Lead Partnerships and Drive Adoption of Its Workday Built Procurement Integration (GlobeNewswire)
Jun-28-25 12:20PM	Jim Cramer on Workday Stock: "I'm Worried" (Insider Monkey)
Jun-26-25 08:00AM	Rain, Toku Debut Stablecoin Payrolls for Workers in Over 100 Countries (CoinDesk)
Jun-25-25 09:01PM	Lightning Round: I am horrified at what is happening at Danaher, says Jim Cramer (CNBC TV)
Jun-24-25 09:00AM	Workday VNDLY Named a Leader in Everest Group's Vendor Management Systems (VMS) PEAK Matrix Assessment 2025 (PR Newswire)
08:00AM	HR Path Expands U.S. Footprint with Acquisition of ClearCourse Consulting (PR Newswire)
Jun-23-25 10:00AM	MetLife and Nayya Expand Access to Upwise via Workday Marketplace (Business Wire)
09:50AM	Here's Why Workday (WDAY) is a Strong Momentum Stock (Zacks)
07:00AM	Kognitiv Completes Acquisition of ClouDevOps to Power Workday Support Capabilities Across Europe (PR Newswire)
Jun-22-25 08:00PM	Millions of Résumés Never Make It Past the Bots. One Man Is Trying to Find Out Why. (The Wall Street Journal)
08:00PM	Loading…
08:00PM	Millions of Resumes Never Make It Past the Bots. One Man Is Trying to Find Out Why. (The Wall Street Journal)
Jun-20-25 07:54AM	How Is Workday's Stock Performance Compared to Other Tech-Software Stocks? (Barchart)
Jun-15-25 05:05AM	Is the Artificial Intelligence Boost Fading for This Top Tech Stock? (Motley Fool)
Jun-13-25 09:45AM	Here's Why Workday (WDAY) is a Strong Growth Stock (Zacks)
Jun-12-25 08:30AM	Workday Achieves Top AI Certifications, Reinforcing Commitment to Responsible AI (PR Newswire)
Jun-11-25 01:02PM	How software giant Workday got 79% of its employees to embrace AI (Fortune)
Jun-10-25 09:00AM	Workday Named a Leader in 2025 Gartner Magic Quadrant for Talent Acquisition (Recruiting) Suites (PR Newswire)
Jun-09-25 12:33AM	3 S&P 500 Stocks Walking a Fine Line (StockStory)
Jun-06-25 09:16AM	Workday (WDAY) Debuts AI Toolset to Customize and Connect AI Apps and Agents on the Workday Platform (Insider Monkey)
Jun-04-25 09:50AM	Why Workday (WDAY) is a Top Momentum Stock for the Long-Term (Zacks)
Jun-03-25 09:15AM	Workday Unveils AI Developer Toolset, Empowering Developers to Customize and Connect AI Apps and Agents on the Workday Platform (PR Newswire)
09:15AM	Workday Announces New AI Agent Partner Network and Agent Gateway to Power the Next Generation of Human and Digital Workforces (PR Newswire)
Jun-02-25 12:25PM	Should You Buy Paylocity Stock Despite its 7% Dip in 3 Months? (Zacks)
May-31-25 07:00AM	MarketBeat Week in Review - 05/26 - 05/30 (MarketBeat)
May-30-25 04:10AM	Workday's Stock Just Dropped, but AI Adoption Is Growing -- Should You Buy the Dip? (Motley Fool)
May-29-25 12:38AM	1 Large-Cap Stock with Competitive Advantages and 2 to Question (StockStory)
May-28-25 01:00PM	Workday Announces Rising 2025: Illuminating the AI-Powered Future of Work (PR Newswire)
09:45AM	Why Workday (WDAY) is a Top Growth Stock for the Long-Term (Zacks)
03:45AM	WDAY Q1 Earnings Call: Revenue Misses Expectations, AI Adoption Drives Strategic Focus (StockStory)
May-27-25 11:32PM	Q1 Earnings Outperformers: Workday (NASDAQ:WDAY) And The Rest Of The Finance and HR Software Stocks (StockStory)
May-26-25 04:47PM	Workday (WDAY)'s AI Push and Margin Beat Lead to $250 Price Target (Insider Monkey)
01:35PM	Workday Stock Price Implosion: An Automatic Buy for AI Investors (MarketBeat)
May-24-25 06:14AM	Why Workday Inc. (WDAY) Crashed On Friday (Insider Monkey)
06:00AM	Workday price target lowered to $295 from $310 at JPMorgan (TipRanks)
04:31AM	JMP Reaffirms Market Outperform Rating on Workday After Mixed Q1 Report (Insider Monkey)
May-23-25 05:57PM	Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit (The Wall Street Journal) -12.52%
05:13PM	S&P 500 Gains & Losses Today: Deckers Outdoor, Ross Stores Stocks Fall as Firms Withhold Outlooks (Investopedia)
12:48PM	Why Workday (WDAY) Stock Is Nosediving (StockStory)
12:00PM	Top Stock Movers Now: Apple, Deckers Outdoor, Intuit, and More (Investopedia)
11:42AM	Workday Q1 Earnings Beat Estimates on Solid Revenue Growth (Zacks)
11:31AM	Workday Stock Tumbles as Firm's Subscription Revenue Outlook Underwhelms (Investopedia)
11:27AM	Stocks to Watch Friday: Apple, Booz Allen, Constellation Energy, Intuit (The Wall Street Journal)
11:22AM	Workday Stock Tumbles After Earnings. Why Its an Overreaction. (Barrons.com)
10:49AM	Quantum stocks, MNTN IPO, Workday earnings: Trending tickers (Yahoo Finance Video)
10:49AM	Stock Market Today: Stocks Fall On Trump Tariff Threat; White House Executive Order Sends Nuclear Stocks Soaring As Nvidia Earnings Loom (Live Coverage) (Investor's Business Daily)
10:49AM	Stock Market Today: Losses Ease From Trump Tariff Threat; Tesla Pulls Itself Out Of The Red (Live Coverage) (Investor's Business Daily)
10:49AM	Stock Market Today: Dow Trims Losses As White House Executive Order Sends Nuclear Stocks Soaring (Live Coverage) (Investor's Business Daily)
10:49AM	Stock Market Today: Dow Jones Falls As Trump Takes Aim At Apple; Nuclear Stock Breaks Out On Executive Order (Live Coverage) (Investor's Business Daily)
09:49AM	CoreWeave Bulls Face Off Against Short Sellers as Shares Spike (Bloomberg)
07:42AM	Q1 2026 Workday Inc Earnings Call (Thomson Reuters StreetEvents)
03:04AM	Workday Inc (WDAY) Q1 2026 Earnings Call Highlights: Strong Subscription Growth and AI ... (GuruFocus.com)
May-22-25 11:34PM	Earnings Loom for Workday (WDAY), Six New AI Agents Draw Attention (Insider Monkey)
06:00PM	Workday (WDAY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:58PM	Markets Mostly Flat; Big Afternoon for Earnings: WDAY, DECK, INTU & More (Zacks)
05:10PM	Workday (WDAY) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:58PM	Workday Logs Higher Revenue, Backs Outlook; Initiates Buyback Program (The Wall Street Journal)
04:25PM	Workday Earnings Top Views. Software Stock Falls On Guidance. (Investor's Business Daily)
04:15PM	Workday: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:06PM	Workday's (NASDAQ:WDAY) Q1: Beats On Revenue (StockStory)
04:01PM	Workday Announces Fiscal 2026 First Quarter Financial Results (PR Newswire)
11:00AM	President Trump's SALT Bill in Focus (Zacks)
10:29AM	Pre-Markets Even Out as Investors Digest Tax Bill (Zacks)
09:09AM	Lawsuit claims discrimination by Workdays hiring tech prevented people over 40 from getting hired (CNN Business)
05:30AM	Workdays discriminatory hiring tech prevented people over 40 from getting hired, lawsuit alleges (CNN Business)
May-21-25 07:00PM	Earnings, existing home sales, Hinge Health IPO: What to Watch (Yahoo Finance Video)
12:31PM	Workday Named a Leader in 2025 Gartner Magic Quadrant for Cloud-Based ERP for U.S. Local Government (PR Newswire)
11:53AM	Workday Unveils Illuminate AI Agents to Accelerate Workflows (Zacks)
04:23AM	Workday Introduces Illuminate AI Agents to Revolutionize Workflows (Insider Monkey)
03:01AM	Workday (WDAY) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
May-20-25 09:30AM	Is Workday (WDAY) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
08:30AM	Workday Names Edward Charter Country Leader for Canada (PR Newswire)
08:22AM	TaskUs and Boot Barn have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:05AM	Prediction: 2 Stocks That Will Be Worth More Than Intel 2 Years From Now (Motley Fool)
May-19-25 12:44PM	Workday Set to Report Q1 Results: Will Revenue Growth Boost Earnings? (Zacks)
12:39PM	Judge allows Workday AI bias lawsuit to proceed as collective action (HR Dive)
09:15AM	Stay Ahead of the Game With Workday (WDAY) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:15AM	Workday Unveils Next Generation of Illuminate Agents to Transform HR and Finance Operations (PR Newswire)
May-18-25 08:13PM	Stock market today: Dow, S&P 500, Nasdaq futures slide after Moody's downgrades US credit rating (Yahoo Finance)
08:13PM	Stock market today: Dow, S&P 500, Nasdaq futures sink after Moody's downgrades US credit rating (Yahoo Finance)
08:13PM	Stock market today: Dow, S&P 500, Nasdaq futures and Asian indexes slide after Moody's downgrades US credit rating (Yahoo Finance)

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Garfield Mark S.	Chief Accounting Officer	Jul 10 '25	Sale	234.86	451	105,922	42,977	Jul 14 04:21 PM
DUFFIELD DAVID A	10% Owner	Jul 08 '25	Sale	239.61	72,551	17,384,110	102,997	Jul 10 04:34 PM
MARK GARFIELD	Officer	Jul 10 '25	Proposed Sale	240.17	451	108,317		Jul 10 04:30 PM
Rowe Zane	Chief Financial Officer	Jul 08 '25	Sale	239.59	6,000	1,437,565	178,418	Jul 08 06:23 PM
ZANE ROWE	Officer	Jul 08 '25	Proposed Sale	241.21	12,000	2,894,520		Jul 08 04:23 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jul 08 '25	Proposed Sale	241.21	72,551	17,500,027		Jul 08 04:21 PM
Eschenbach Carl M.	CEO	Jul 01 '25	Sale	239.43	6,250	1,496,435	1,472	Jul 03 04:52 PM
DUFFIELD DAVID A	10% Owner	Jul 01 '25	Sale	238.96	72,917	17,424,176	102,997	Jul 03 04:39 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jul 01 '25	Proposed Sale	240.00	72,917	17,500,080		Jul 01 04:23 PM
DUFFIELD DAVID A	10% Owner	Jun 24 '25	Sale	238.66	73,971	17,654,071	102,997	Jun 26 04:35 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 24 '25	Proposed Sale	236.58	73,971	17,500,059		Jun 24 04:25 PM
DUFFIELD DAVID A	10% Owner	Jun 17 '25	Sale	244.31	71,240	17,404,482	102,997	Jun 18 04:36 PM
DUFFIELD DAVID A	10% Owner	Jun 16 '25	Sale	245.33	15,000	3,679,932	30,000	Jun 18 04:36 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 17 '25	Proposed Sale	245.65	71,240	17,500,106		Jun 17 04:21 PM
The Dave & Cheryl Duffield Fou	10% Owner	Jun 16 '25	Proposed Sale	244.54	15,000	3,668,100		Jun 16 04:32 PM
STILL GEORGE J JR	Director	Jun 05 '25	Sale	248.41	7,500	1,863,101	67,500	Jun 09 04:46 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Jun 05 '25	Proposed Sale	249.48	7,500	1,871,100		Jun 05 05:04 PM
DUFFIELD DAVID A	10% Owner	Jun 02 '25	Sale	246.84	70,648	17,438,932	102,997	Jun 03 04:29 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 02 '25	Proposed Sale	247.71	70,648	17,500,216		Jun 02 04:28 PM
Eschenbach Carl M.	CEO	May 27 '25	Sale	241.23	3,125	753,844	7,722	May 29 06:38 PM
ESCHENBACH FAMILY TRUST	Director	May 27 '25	Proposed Sale	238.01	9,375	2,231,344		May 27 04:34 PM
SAYAN CHAKRABORTY	Officer	May 27 '25	Proposed Sale	238.01	12,860	3,060,809		May 27 04:30 PM
Garfield Mark S.	Chief Accounting Officer	Apr 10 '25	Sale	226.55	497	112,595	34,385	Apr 14 06:38 PM
DUFFIELD DAVID A	10% Owner	Apr 08 '25	Sale	214.68	81,275	17,448,053	102,997	Apr 10 04:37 PM
MARK GARFIELD	Officer	Apr 10 '25	Proposed Sale	231.42	497	115,016		Apr 10 04:17 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Apr 08 '25	Proposed Sale	215.32	81,275	17,500,133		Apr 08 04:16 PM
Eschenbach Carl M.	CEO	Apr 02 '25	Sale	234.61	3,125	733,161	10,847	Apr 04 06:14 PM
DUFFIELD DAVID A	10% Owner	Apr 01 '25	Sale	232.94	74,937	17,455,544	102,997	Apr 03 04:08 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Apr 01 '25	Proposed Sale	233.53	74,937	17,500,038		Apr 01 04:26 PM
DUFFIELD DAVID A	10% Owner	Mar 24 '25	Sale	250.26	70,144	17,554,502	102,997	Mar 26 04:58 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 24 '25	Proposed Sale	249.49	70,144	17,500,227		Mar 24 04:22 PM
DUFFIELD DAVID A	10% Owner	Mar 17 '25	Sale	248.58	71,672	17,816,346	102,997	Mar 18 07:00 PM
DUFFIELD DAVID A	10% Owner	Mar 14 '25	Sale	243.17	15,000	3,647,531	45,000	Mar 18 07:00 PM
STILL GEORGE J JR	Director	Mar 13 '25	Sale	241.33	7,500	1,809,991	75,000	Mar 17 07:16 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 17 '25	Proposed Sale	244.17	71,672	17,500,152		Mar 17 04:32 PM
The Dave & Cheryl Duffield Fou	10% Owner	Mar 14 '25	Proposed Sale	237.22	15,000	3,558,300		Mar 14 04:25 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Mar 13 '25	Proposed Sale	241.67	7,500	1,812,525		Mar 13 04:25 PM
DUFFIELD DAVID A	10% Owner	Mar 03 '25	Sale	259.52	66,455	17,246,098	102,997	Mar 05 05:42 PM
Chakraborty Sayan	President, Prod. and Tech.	Feb 27 '25	Sale	265.50	6,056	1,607,858	111,324	Mar 03 07:32 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 03 '25	Proposed Sale	263.34	66,455	17,500,260		Mar 03 04:23 PM
SAYAN CHAKRABORTY	Officer	Feb 27 '25	Proposed Sale	271.09	6,056	1,641,721		Feb 27 04:26 PM
Garfield Mark S.	Chief Accounting Officer	Jan 13 '25	Sale	248.24	472	117,169	35,408	Jan 15 04:33 PM
DUFFIELD DAVID A	10% Owner	Jan 13 '25	Sale	246.42	56,000	13,799,530	60,000	Jan 15 04:32 PM
MARK GARFIELD	Officer	Jan 13 '25	Proposed Sale	249.71	472	117,863		Jan 13 04:25 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Jan 13 '25	Proposed Sale	249.71	56,000	13,983,760		Jan 13 04:24 PM
DUFFIELD DAVID A	10% Owner	Jan 08 '25	Sale	254.53	70,090	17,839,895	102,997	Jan 10 04:17 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jan 08 '25	Proposed Sale	249.68	70,090	17,500,071		Jan 08 04:21 PM
Eschenbach Carl M.	CEO	Jan 06 '25	Sale	253.86	6,250	1,586,654	13,972	Jan 07 09:19 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Jan 07 '25	Sale	251.90	3,677	926,232	79,576	Jan 07 09:16 PM
DUFFIELD DAVID A	10% Owner	Jan 06 '25	Sale	253.87	56,000	14,216,609	116,000	Jan 07 07:30 PM
RICHARD SAUER	Officer	Jan 07 '25	Proposed Sale	254.14	3,677	934,473		Jan 07 04:17 PM
DUFFIELD DAVID A	10% Owner	Jan 02 '25	Sale	252.83	67,822	17,147,554	102,997	Jan 06 04:29 PM
ESCHENBACH FAMILY TRUST	Director	Jan 06 '25	Proposed Sale	252.84	12,500	3,160,500		Jan 06 04:27 PM
Frederick Wayne A.I.	Director	Jan 02 '25	Sale	253.09	1,829	462,904	6,845	Jan 06 04:25 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Jan 06 '25	Proposed Sale	252.84	56,000	14,159,040		Jan 06 04:23 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jan 02 '25	Proposed Sale	258.03	67,822	17,500,111		Jan 02 04:26 PM
WAYNE FREDERICK	Director	Jan 02 '25	Proposed Sale	258.03	1,829	471,937		Jan 02 04:25 PM
DUFFIELD DAVID A	10% Owner	Dec 30 '24	Sale	261.75	56,000	14,657,896	172,000	Dec 31 04:40 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Dec 30 '24	Proposed Sale	266.24	56,000	14,909,440		Dec 30 04:10 PM
DUFFIELD DAVID A	10% Owner	Dec 23 '24	Sale	265.70	56,000	14,878,925	228,000	Dec 26 04:44 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Dec 23 '24	Proposed Sale	273.04	56,000	15,290,240		Dec 23 04:18 PM
DUFFIELD DAVID A	10% Owner	Dec 18 '24	Sale	275.31	57,000	15,692,813	284,000	Dec 20 04:19 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Dec 18 '24	Proposed Sale	278.01	57,000	15,846,570		Dec 18 04:26 PM
STILL GEORGE J JR	Director	Dec 16 '24	Sale	276.54	7,500	2,074,041	82,500	Dec 18 04:22 PM
DUFFIELD DAVID A	10% Owner	Dec 16 '24	Sale	276.56	63,946	17,684,813	102,997	Dec 18 04:18 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Dec 16 '24	Proposed Sale	273.67	7,500	2,052,525		Dec 16 04:37 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 16 '24	Proposed Sale	273.67	63,946	17,500,102		Dec 16 04:37 PM
James Bozzini	Director	Dec 09 '24	Proposed Sale	279.91	18,696	5,233,197		Dec 09 05:25 PM
DUFFIELD DAVID A	10% Owner	Dec 02 '24	Sale	251.20	70,003	17,585,013	102,997	Dec 04 06:25 PM
Chakraborty Sayan	President, Prod. and Tech.	Nov 29 '24	Sale	250.78	5,498	1,378,767	121,100	Dec 03 05:39 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 02 '24	Proposed Sale	249.99	70,003	17,500,050		Dec 02 04:44 PM
SAYAN CHAKRABORTY	Officer	Nov 29 '24	Proposed Sale	253.40	5,498	1,393,193		Nov 29 01:43 PM
DUFFIELD DAVID A	10% Owner	Oct 14 '24	Sale	242.01	56,000	13,552,624	281,000	Oct 15 05:07 PM
Frederick Wayne A.I.	Director	Oct 11 '24	Sale	241.85	1,828	442,106	8,674	Oct 15 04:12 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Oct 14 '24	Proposed Sale	240.90	56,000	13,490,400		Oct 15 08:01 AM
WAYNE FREDERICK	Director	Oct 11 '24	Proposed Sale	245.16	1,828	448,152		Oct 11 04:20 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Oct 08 '24	Sale	235.78	3,134	738,936	85,795	Oct 10 05:12 PM
DUFFIELD DAVID A	10% Owner	Oct 08 '24	Sale	238.37	74,320	17,715,903	102,997	Oct 09 04:40 PM
DUFFIELD DAVID A	10% Owner	Oct 07 '24	Sale	236.90	56,000	13,266,382	337,000	Oct 09 04:40 PM
RICHARD SAUER	Officer	Oct 08 '24	Proposed Sale	235.47	3,134	737,963		Oct 08 04:22 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Oct 08 '24	Proposed Sale	235.47	74,320	17,500,130		Oct 08 04:22 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Oct 07 '24	Proposed Sale	242.35	56,000	13,571,600		Oct 07 04:21 PM
DUFFIELD DAVID A	10% Owner	Oct 01 '24	Sale	240.59	71,601	17,226,807	102,997	Oct 02 04:37 PM
DUFFIELD DAVID A	10% Owner	Sep 30 '24	Sale	242.96	56,000	13,605,933	393,000	Oct 02 04:37 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Oct 01 '24	Proposed Sale	244.41	71,601	17,500,000		Oct 01 04:34 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Sep 30 '24	Proposed Sale	243.62	56,000	13,642,720		Sep 30 04:23 PM
DUFFIELD DAVID A	10% Owner	Sep 23 '24	Sale	245.36	56,000	13,740,164	449,000	Sep 25 04:30 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Sep 23 '24	Proposed Sale	248.29	56,000	13,904,240		Sep 23 04:21 PM
DUFFIELD DAVID A	10% Owner	Sep 18 '24	Sale	247.59	57,000	14,112,778	505,000	Sep 20 04:19 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Sep 18 '24	Proposed Sale	248.12	57,000	14,142,840		Sep 18 04:42 PM
DUFFIELD DAVID A	10% Owner	Sep 16 '24	Sale	249.15	69,986	17,437,109	102,997	Sep 18 04:21 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Sep 16 '24	Proposed Sale	250.05	69,986	17,499,999		Sep 16 04:39 PM
STILL GEORGE J JR	Director	Sep 05 '24	Sale	255.45	7,500	1,915,895	90,000	Sep 09 07:13 PM
DUFFIELD DAVID A	10% Owner	Sep 03 '24	Sale	261.20	66,492	17,367,531	102,997	Sep 05 05:14 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Sep 03 '24	Proposed Sale	263.19	66,492	17,500,029		Sep 03 04:20 PM
STILL GEORGE J JR	Director	Aug 26 '24	Sale	260.32	7,500	1,952,398	97,500	Aug 28 07:00 PM
Robinson Douglas A.	Co-President	Aug 26 '24	Sale	260.29	3,121	812,370	196,344	Aug 28 06:58 PM
Chakraborty Sayan	Co-President	Aug 26 '24	Sale	260.26	5,496	1,430,362	130,876	Aug 28 06:53 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Aug 26 '24	Proposed Sale	259.95	15,000	3,899,250		Aug 26 04:26 PM
SAYAN CHAKRABORTY	Officer	Aug 26 '24	Proposed Sale	259.95	5,496	1,428,685		Aug 26 04:26 PM

TEM

Tempus AI Inc

PODD

Insulet Corporation

WDAY

Workday Inc

Upgrade your FINVIZ experience